HIV and splenectomy: 3 cases and review of the literature;Infection VIH et splenectomie: Trois cas et revue de la litterature

Schweizerische Medizinische Wochenschrift

Volumn 126, Issue 36, 1996, Pages 1524-1529

  Greub, G ^a   Erard, Ph ^b   Von Overbeck, J ^b  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; PNEUMOCOCCUS VACCINE; STREPTOCOCCUS VACCINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; SPLENECTOMY; STREPTOCOCCUS PNEUMONIAE; VACCINATION; AIDS RELATED COMPLEX; BACTERIAL INFECTION; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; IMMUNOLOGY; REVIEW;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; BACTERIAL INFECTIONS; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; FEMALE; HIV INFECTIONS; HUMANS; MALE; SPLENECTOMY;

EID: 0029758437     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Joag SV, Stephens EB, Adams RJ, Foresman L, Narayan O: Pathogenesis of SIVmac infection in Chinese and Indian rhesus macaques: effects of splenectomy on virus burden. Virology 1994; 200: 436-446.
2. Brown SS, Majumdar G, Harrington C, Bedford M, Winter M et al.: Effect of splenectomy on HIV-related thrombocytopenia and progression of HIV infection in patients with severe haemophilia. Blood Coagul Fibrinolysis 1994; 5: 393-397.
3. Tunkel AR, Kelsall B, Rein MF, Innes DJ, Saulsburry FT et al.: Case reports: increase in CD4 lymphocyte counts after splenectomy in HIV-infected patients. Am J Med Sci 1993; 306: 105-110.
4. Mac Donnell KB, Chimel JS, Poggensee L, Wu S, Phair JP: Predicting progression to AIDS: combined usefulness of CD4 lymphocyte count and p24 antigenemia. Am J Med 1990; 89: 706-712.
5. Phillips AN, Lee AC, Elford J, Jannossy G, Timms A et al.: Serial CD4 lymphocyte counts and development of AIDS. Lancet 1991; 337: 389-392.
6. Ho D, Moudgil T, Alam M: Quantification of human immunodeficiency virus type 1 in the blood of infected persons. N Engl J Med 1989; 321: 1621-1625.
7. Fairley CK, Spelman D, Street A, Jennens ID, Spicer WJ et al.: CD4 lymphocyte numbers after splenectomy in patients infected with the human immunodeficiency virus. Int J STD AIDS 1994; 5: 177-181.
8. Boudes P, Casassus PH, Guillevin I: Attention à l'interprétation du taux de lymphocyte CD4 après splénectomie chez les sujets infectés par le VIH. Ann Med Intern 1988; 139: 523.
9. Coyle T, Cynamon M, Blair D, Poiesz BJ: Changes in the lymphocyte count and lymphocyte subsets after splenectomy in HIV infection. Am J Hematol 1992; 41: 144-146.
10. Zurlo JJ, Wood L, Gaglione MM, Polis MA: Effect of splenectomy on T lymphocyte subsets in patients infected with the HIV. Clin Infect Dis 1995; 20: 768-771.
11. Imam N, Carpenter CC, Mayer KH, Fisher A, Stein M et al.: Hierarchical pattern of mucosal Candida infections in HIV-seropositive women. Am J Med 1990; 89: 142-146.
12. Sangeorzan JA, Bradley SF, He X, Zarins LT, Ridenour GL et al.: Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994; 97: 339-346.
13. Lifson AR, Hilton JF, Westenhouse JL, Canchola AJ, Samuel MC et al.: Time from HIV seroconversion to oral candidiasis or hairy leukoplakia among homosexual and bisexual men enrolled in three prospective cohorts. AIDS 1994; 8: 73-79.
14. Connolly GM, Hawkins D, Harcourt-Webster JN, Parsons PA, Husain OA, Gazzard BG: Oesophageal symptoms, their causes, treatment, and prognosis in patients with the acquired immunodeficiency syndrome. Gut 1989; 30: 1033-1039.
15. Smith KJ, Skelton HG, Yeager J, Ledsky R, McCarthy W et al.: Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. Military Medical Consortium for the Advancement of Retroviral Research. Am J Acad Dermatol 1994; 31: 746-754.
16. Froschl M, Land HG, Landthaler M: Seborrheic dermatitis and atopic eczema in human immunodeficiency virus infection. Semin Dermatol 1990; 9: 230-232.
17. Perronne C, Lazanas M, Bellou A, Leport C, Canton P, Vilde JL: Zona in 50 patients infected by human immunodeficiency virus. Clinical manifestations and prognostic value. Presse Med 1990; 19: 752-754.
18. Fish DN, Danziger LH: Neglected pathogens: bacterial infections in persons with human immunodeficiency virus infection. A review of the literature. Pharmacotherapy 1993; 13: 415-439.
19. Casadevall A, Dobroszycki J, Small C, Pirofski LA: Haemophilus influenzae type b bacteremia in adults with AIDS and at risk for AIDS. Am J Med 92: 1992; 587-590.
20. Ambrosino DM, Lee MY, Chen D, Shamberger RC: Response to Haemophilus influenzae type b conjugate vaccine in children undergoing splenectomy. J Pediatr Surg 1992; 27: 1045-1047.
21. Holdsworth RJ, McKenzie H, Parratt D, Irving AD, Cuschieri A: The role of the spleen in the immune response following naturally acquired exposure to encapsulated bacteria. Int J Exp Pathol 1990; 71: 835-843.
22. Flegg PJ, Brettle RP, Bell JE, Bird AG, Busuttil A: Fatal pneumococcal meningitis in an HIV-infected drug user despite previous pneumococcal immunization. Int J STD AIDS 1994; 5: 221-222.
23. Genet P, Lionnet F, Pulik M, Petitdidier C, Le Turdu F: Severe pneumococcal infections in splenectomized HIV-positive patients. AIDS 1994; 8: 850-851.
24. Lortan JE: Management of asplenic patients. Br J Haematol 1993; 84: 566-569.
25. Glaser JB, Volpe S, Aguirre A, Simpkins H, Schiffman G: Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J Infect Dis 1991; 164: 761-764.
26. Rodriguez-Barradas MC, Musher DM, Lahart C et al.: Antibody to capsular polysaccharides of Streptococcus pneumoniae after vaccination of human immunodeficiency virus-infection subjects with 23-valent pneumococcal vaccine. J Infect Dis 1992; 165: 553-556.
27. Rose DN, Schechter CB, Sacks HS: Influenza and pneumococcal vaccination of HIV-infected patients: a policy analysis. Am J Med 1993; 94: 160-168.
28. Bruyn BAW, Hiemastra PS, Rijkers GT: Type-specific antipneumococcal vaccinated patient with combined immunoglobulin A and IgG2 deficiency and invasive pneumococcal infections. J Infect Dis 1992; 166: 1460-1461.
29. Steinhart R, Reingold AR, Taylor F, Anderson G, Wenger JD: Invasive Haemophilus influenzae infections in men with HIV infection. JAMA 1992; 268: 3350-3352.
30. Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF et al.: CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus infection. Ann Intern Med 1989; 111: 223-231.
31. Lidman C, Berglund O, Tynell E, Lindback S: CD4+ cells and CD4+ percent as risk markers for Pneumocystis carinii pneumonia: implications for primary prophylaxis. Scand J Infect Dis 1992; 24: 157-160.
32. Goedert JJ: Prognostic markers for AIDS. Ann Epidemiol 1990; 1: 129-139.
33. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M et al.: HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993; 362: 355-358.
34. Margolick JB, Munoz A, Donnenberg AD, Park LP, Galai N et al.: Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. Nature Medicine 1995; 1: 674-680.
35. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Marlcowitz M: Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995; 373: 123-126.
36. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA et al.: Viraldynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117-122.